StreetInsider.com News Articles

BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026

Thu, 08 Oct 2026 16:15:00 -0400

FRANKLIN LAKES, N.J., Oct. 8, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, November 5, 2026 to discuss the Company's financial results for its fourth quarter and full year of fiscal 2026, which ended on September 30, 2026, and to provide an update on its operations and strategy. The audio webcast

BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026

Thu, 08 Oct 2026 16:15:00 -0400

BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide

Thu, 08 Oct 2026 06:50:00 -0400

Physicians, policymakers, and global health experts urge broader access to monitoring technologies that can help identify life-threatening complications earlier, helping more mothers survive childbirth and giving babies a healthier start in life.

FRANKLIN LAKES, N.J., Oct. 8, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, the Global Surgery Foundation (GSF) and the

BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide

Thu, 08 Oct 2026 06:50:00 -0400

FRANKLIN LAKES, N.J., Oct. 8, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, the Global Surgery Foundation (GSF) and the

BD reports nine-month AGILITY trial results for iliac artery stent

Wed, 07 Oct 2026 08:03:11 -0400

BD (Becton, Dickinson and Company) (NYSE: BDX) announced nine-month results from the iliac cohort of the AGILITY Investigational Device Exemption trial, evaluating its Revello™ Vascular Covered Stent in patients with iliac artery disease.

The data were presented at the VIVA 2026 conference by Sean Lyden, M.D., chairman of the Department of Vascular Surgery at Cleveland Clinic and global lead principal investigator for the trial.

The iliac cohort enrolled 120 patients across 28 investigational sites in the United States, Europe, Australia, and New Zealand. Key nine-month outcomes included a composite safety and effectiveness endpoint failure rate of 2.8%, compared with a prespecified performance

BD reports nine-month AGILITY trial results for iliac artery stent

Wed, 07 Oct 2026 08:03:11 -0400

The data were presented at the VIVA 2026 conference by Sean Lyden, M.D., chairman of the Department of Vascular Surgery at Cleveland Clinic and global lead principal investigator for the trial.

BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results

Wed, 07 Oct 2026 08:00:00 -0400

Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac artery disease.

FRANKLIN LAKES, N.J., Oct. 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced positive nine-month

BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results

Wed, 07 Oct 2026 08:00:00 -0400

FRANKLIN LAKES, N.J., Oct. 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced positive nine-month

Barclays Starts Becton Dickinson (BDX) at Underweight

Tue, 06 Oct 2026 16:25:09 -0400

Barclays analyst Travis Steed initiates coverage on Becton Dickinson (NYSE: BDX) with a Underweight rating and a price target of $165.00.

For an analyst ratings summary and ratings history on Becton Dickinson click here. For more ratings news on Becton Dickinson click here.

Shares of Becton Dickinson closed at $180.67 yesterday.

BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan

Tue, 06 Oct 2026 09:00:00 -0400

Generations of Connecticut employees have helped ensure the reliable supply of the BD® Syringe, an essential medical device clinicians rely on every day in patient care around the world

CANAAN, Conn., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked 65 years of manufacturing in

BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan

Tue, 06 Oct 2026 09:00:00 -0400

Generations of Connecticut employees have helped ensure the reliable supply of the BD® Syringe, an essential medical device clinicians rely on every day in patient care around the world

CANAAN, Conn., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked 65 years of manufacturing in

BD names Ferass Abuzaina worldwide president of Surgery unit

Tue, 06 Oct 2026 06:50:15 -0400

Becton, Dickinson and Company (NYSE: BDX), known as BD, announced that Ferass Abuzaina has been named worldwide president of its Surgery business unit, effective immediately, according to a company press release.

Abuzaina will oversee the global strategic, operational, and commercial performance of the Surgery unit. He will be based at BD Surgery's headquarters in Warwick, RI, and will report to Peter Menziuso, executive vice president and president of the Interventional segment.

"Surgery is well-positioned for its next chapter of growth, and Ferass is the right leader to help us build on that momentum," Menziuso said. "He combines a deep understanding of our

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

Tue, 06 Oct 2026 06:50:00 -0400

FRANKLIN LAKES, N.J., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Ferass Abuzaina has been named worldwide president of the Surgery business unit at BD, effective immediately.

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

Tue, 06 Oct 2026 06:50:00 -0400

BD strikes $19 billion U.S. manufacturing deal with federal government

Tue, 06 Oct 2026 06:37:36 -0400

Becton, Dickinson and Company (NYSE: BDX) announced an agreement with the U.S. government to expand domestic production of essential medical consumables, according to a company press release dated Oct. 6, 2026.

Under the agreement, BD plans to invest $19 billion in the U.S. over several years, covering capital, operational and supply chain expenditures. Of that total, $3 billion is directed toward U.S. manufacturing expansion across multiple production sites.

The company said it intends to increase domestic output by approximately 5 billion essential medical consumables annually, which it said would raise its share of domestically supplied essential medical consumables to roughly 80%. BD

BD strikes $19 billion U.S. manufacturing deal with federal government

Tue, 06 Oct 2026 06:37:36 -0400

BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience

Tue, 06 Oct 2026 06:35:00 -0400

Agreement supports significant investments in U.S. manufacturing, strengthens healthcare resilience and increases domestic production of essential medical consumables used in approximately 90% of U.S. hospital visits  

FRANKLIN LAKES, N.J., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), one of the world's leading medical technology companies and the nation's largest manufacturer of essential medical consumables,

BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience

Tue, 06 Oct 2026 06:35:00 -0400

Form 4 BECTON DICKINSON & CO For: Sep 28 Filed by: Feld Michael

Tue, 29 Sep 2026 21:14:00 -0400

si-local-file:///var/storage/secattach/20260929/27123835.html

BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy

Tue, 29 Sep 2026 09:00:00 -0400

Generations of Utah employees have helped ensure the reliable supply of essential medical devices that clinicians use every day to care for patients around the world

SANDY, Utah, Sept. 29, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked 70 years of manufacturing in

BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy

Tue, 29 Sep 2026 09:00:00 -0400

Generations of Utah employees have helped ensure the reliable supply of essential medical devices that clinicians use every day to care for patients around the world

SANDY, Utah, Sept. 29, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked 70 years of manufacturing in

Form 144 BECTON DICKINSON & CO Filed by: Feld Michael

Mon, 28 Sep 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260928/27114750.html

BD names Arthur Hu as chief information and digital officer

Mon, 21 Sep 2026 16:31:12 -0400

BD (Becton, Dickinson and Company) (NYSE: BDX) announced that Arthur Hu has been named executive vice president and chief information and digital officer, effective September 30, 2026, according to a company press release.

Hu joins BD from Lenovo Group, where he most recently served as senior vice president, global chief information officer and chief technology and delivery officer for the Solutions and Services Group. His responsibilities at Lenovo included leading digital technology, AI adoption and business transformation across customer, partner and employee-facing platforms.

Before Lenovo, Hu spent over a decade at McKinsey & Company advising organizations on technology, operations, strategy and organizational

BD names Arthur Hu as chief information and digital officer

Mon, 21 Sep 2026 16:31:12 -0400

Before Lenovo, Hu spent over a decade at McKinsey & Company advising organizations on technology, operations, strategy and organizational

Arthur Hu to Join BD as Chief Information and Digital Officer

Mon, 21 Sep 2026 16:30:00 -0400

FRANKLIN LAKES, N.J., Sept. 21, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Arthur (Art) Hu has been named executive vice president and chief information and digital officer, effective September 30.